B
ANAC

Baird’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Baird’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$3.87M Sell
66,958
-22,191
-25% -$942K 0.04% 399
2014
Q4 		$2.88M Sell
89,149
-5,970
-6% -$179K 0.03% 458
2014
Q3 		$2.33M Buy
95,119
+1,684
+2% +$34.2K 0.03% 430
2014
Q2 		$1.66M Buy
93,435
+49,408
+112% +$795K 0.02% 528
2014
Q1 		$881K Sell
44,027
-33,384
-43% -$647K 0.01% 666
2013
Q4 		$1.3M Buy
+77,411
New +$1.07M 0.02% 541

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Baird's ANAC Position: Q1 2015 in Review

Baird reduced its ANACOR PHARMACEUTICALS INC COM (ANAC) stake by 25% in Q1 2015, selling an estimated $942K and leaving 66,958 shares worth $3.87M. The position accounts for 0.04% of the portfolio, ranked #399.

Baird first reported a position in ANAC in Q4 2013 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

  • Baird held 66,958 shares of ANACOR PHARMACEUTICALS INC COM worth $3.87M as of Q1 2015.
  • Baird sold 22,191 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $942K.
  • ANACOR PHARMACEUTICALS INC COM made up 0.04% of Baird's portfolio in Q1 2015, its #399 holding.
  • Baird first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.